Cyclopharm Limited

Cyclopharm Limitedverified

CYC.AX

Price:

$0.575

Market Cap:

$72.49M

Cyclopharm Limited is an international enterprise specializing in the production and global distribution of medical devices and radiopharmaceuticals, with operations spanning Asia Pacific, Europe, Canada, and other regions. The company's business activities are structured into two principal divisions: Technegas and Molecular Imaging. Through its Technegas segment, Cyclopharm supplies diagnostic apparatus and accompanying consumables critical for clinicians in the identification of pulmonary embolisms, alongside distributing third-party offerings to the broader diagnostic imaging sector. Conversely, the Molecular Imaging division provides advanced radiopharmaceutical agents essential for medi...[Read more]

Industry

Medical - Devices

IPO Date

2007-01-17

Stock Exchange

ASX

Ticker

CYC.AX

The PE Ratio as of June 2026 (TTM) for Cyclopharm Limited (CYC.AX) is -3.59

According to Cyclopharm Limited’s latest financial reports and current stock price. The company's current PE Ratio is -3.59. This represents a change of -23.64% compared to the average of -4.70 of the last 4 quarters.

Cyclopharm Limited (CYC.AX) Historical PE Ratio (quarterly & annually)

How has CYC.AX PE Ratio performed in the past?

The mean historical PE Ratio of Cyclopharm Limited over the last ten years is -227.72. The current -3.59 PE Ratio has changed 57.65% with respect to the historical average. Over the past ten years (40 quarters), CYC.AX's PE Ratio was at its highest in in the December 2019 quarter at 205.95. The PE Ratio was at its lowest in in the December 2017 quarter at -194.25.

Quarterly (TTM)
Annual

Average

-227.72

Median

-28.37

Minimum

-2128.02

Maximum

56.94

Cyclopharm Limited (CYC.AX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cyclopharm Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 4.68%

Maximum Annual PE Ratio = 56.94

Minimum Annual Increase = -178.21%

Minimum Annual PE Ratio = -2128.02

Quarterly (TTM)
Annual
YearPE RatioChange
2025-6.27-49.43%
2024-12.39-67.43%
2023-38.04131.25%
2022-16.45-43.55%
2021-29.15-8.01%
2020-31.6814.79%
2019-27.60-98.70%
2018-2128.024.68%
2017-44.53-178.21%
201656.94842.24%

Cyclopharm Limited (CYC.AX) Average PE Ratio

How has CYC.AX PE Ratio performed in the past?

The current PE Ratio of Cyclopharm Limited (CYC.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-18.90

5-year avg

-20.46

10-year avg

-227.72

Cyclopharm Limited (CYC.AX) PE Ratio vs. Peers

How is CYC.AX’s PE Ratio compared to its peers?

Cyclopharm Limited’s PE Ratio is less than Micro-X Limited (-2.09), less than ImpediMed Limited (-0.50), greater than Mach7 Technologies Limited (-6.99), less than Genetic Signatures Limited (-1.49), less than Compumedics Limited (439.84), greater than Amplia Therapeutics Limited (-7.32), greater than Beamtree Holdings Limited (-4.78), greater than Medical Developments International Limited (-99.48), greater than Cynata Therapeutics Limited (-7.23), less than CleanSpace Holdings Limited (17.75),

Build a custom stock screener for Cyclopharm Limited (CYC.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cyclopharm Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cyclopharm Limited (CYC.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cyclopharm Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Cyclopharm Limited's PE Ratio?

How is the PE Ratio calculated for Cyclopharm Limited (CYC.AX)?

What is the highest PE Ratio for Cyclopharm Limited (CYC.AX)?

What is the 3-year average PE Ratio for Cyclopharm Limited (CYC.AX)?

What is the 5-year average PE Ratio for Cyclopharm Limited (CYC.AX)?

How does the current PE Ratio for Cyclopharm Limited (CYC.AX) compare to its historical average?